NEW YORK, Jan. 17, 2017 -- TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Chesapeake IRB has integrated its IRB platform with the Trial Interactive electronic Trial Master File (eTMF) and study start-up solution to streamline global trial management for sponsors and CROs.
Trial Interactive is a web-based, 21 CFR Part 11-compliant platform that eliminates the redundancies inherent in paper-based study start-up and TMF management. By providing real-time access to clinical trial documentation as well as automated status notifications for protocols and investigative sites, the integration reduces the time and costs of manually managing IRB-related documentation.
CIRBI (Center for IRB Intelligence) is Chesapeake IRB’s completely paperless, cloud-based, 21 CFR Part 11-compliant protocol submission and management platform. CIRBI streamlines electronic submissions for all IRB actions and provides complete and rapid delivery of all IRB data and artifacts through its advanced IRB-CONNECT™ technology.
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, stated, “We have daily interaction with our eTMF and study start-up clients who use or are planning to use Chesapeake IRB as their central IRB. We have had an ongoing commitment to eliminate inefficiencies in the conduct of clinical trials and the IRB documentation that needs to be rapidly available to allow for faster site activation and ultimately wind up in the TMF is critical. This process to date is still fairly inefficient requiring a lot of manual work and we were easily able to collaborate with Chesapeake, due to their state-of-the-art platform, to eliminate this manual process of getting thousands of documents seamlessly into the Trial Interactive eTMF for our mutual clients.”
“Many of Chesapeake’s clients are moving to an eTMF environment and want an efficient way to have IRB-related documents automatically transferred into the eTMF with relevant metadata for auto-filing in the right place in real time without a tedious and error-prone process. Integration with Trial Interactive is a great benefit to our mutual and potential clients using the eTMF solution,” said Jeffrey Wendel, President and CEO of Chesapeake IRB. “With its paperless process and global document management capabilities, Trial Interactive helps our customers streamline site activation and accelerate start-up timelines while meeting regulatory requirements and facilitating remote inspections. It’s a win for the life sciences industry.”
TransPerfect Co-CEO Phil Shawe stated, “Chesapeake IRB has a sterling reputation, and the shared attributes between CIRBI and Trial Interactive represented a significant opportunity for us to collaborate. The result is a robust, paperless solution with a wide range of applications that will help us to deliver greater value to our clients.”
Liz Elting, Co-CEO of TransPerfect, added, “Any opportunity to make things easier on our clients is something we welcome with open arms. In this case, we’ve been able to work with Chesapeake to produce an integrated solution that will be a game changer in the eTMF and IRB world, and we’re confident that the time and cost savings will be both immediate and significant.”
About Chesapeake IRB
Chesapeake IRB, an AAHRPP-accredited company, provides independent IRB submission and review services to pharmaceutical, biotech and medical device companies as well as academic medical centers and hospital systems. Its paperless, cloud-based submission and review platform, CIRBI, leads the field and has set the standard in review turnaround time, quality and document accessibility. Headquartered in Columbia, Md., Chesapeake IRB has offices across the United States and a wholly owned subsidiary, IRB Services, with offices in Toronto and Montreal, Canada. Visit chesapeakeirb.com for more information.
About TransPerfect
With annual revenues of more than $540 million, TransPerfect is the world's largest privately held provider of language services and technology solutions. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 3,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.
Contact: Ryan Simper +1 212.689.5555 [email protected]


First Western Ship Transits Strait of Hormuz Since Iran War Began
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 



